Skip to main content
. 2014 Nov 21;7:679–687. doi: 10.2147/JPR.S70200

Figure 4.

Figure 4

Mean change from randomization in Fibromyalgia Impact Questionnaire-Revised total scores in (A) ≥30% to <50% pain reduction subgroup and (B) <30% pain reduction subgroup.

Notes: *P<0.05 versus milnacipran; **P<0.01; ***P<0.001.